Table 1.
Antibody staining patterns in study groups
| Patterns | Homogeneous | Speckled | Nucleolar | Nucleolar dots | Nucleolar membrane | Speckled/ nucleolar | Nucleolar/ homogeous | Total [sum of positives (%)] |
|---|---|---|---|---|---|---|---|---|
| Study groups | ||||||||
| sGWV (n = 130) | 4 | 3 | 2 | 1 | 10 (8%) | |||
| wGWV (n = 90) | 1 | 2 | 3 (3%) | |||||
| sBEV (n = 128) | 7 | 2 | 1 | 1 | 11 (9%) | |||
| HC group A (for GW group) | 2 | 2 | 2 | 6 (12%) | ||||
| (n = 51) | ||||||||
| CFS (n = 100) | 9 | 7 | 1 | 1 | 18 (18%) | |||
| HC group B (for CFS) (n = 111) | 7 | 6 | 4 | 1 | 18 (16%) | |||
sGWV, sick Gulf War veterans; wGWV, well Gulf War veterans; sBEV, sick Bosnia and Era veterans; CFS, Chronic Fatigue Syndrome patients; HC, Healthy controls.